Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/02/2874670/0/en/Oncternal-Therapeutics-to-Provide-Business-Update-and-Report-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/01/2873281/0/en/Oncternal-Therapeutics-Reports-Inducement-Award-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/04/18/2865429/0/en/Oncternal-Announces-First-Patient-Dosed-in-Fourth-Cohort-of-Phase-1-2-Study-of-ONCT-534-for-the-Treatment-of-R-R-Metastatic-Castration-Resistant-Prostate-Cancer.html
https://www.globenewswire.com//news-release/2024/03/15/2847056/0/en/Oncternal-Participating-in-Virtual-Fireside-Chat-with-Key-Opinion-Leader-on-Treatment-Landscape-New-Treatment-Options-for-Prostate-Cancer.html
https://www.globenewswire.com//news-release/2024/03/07/2842710/0/en/Oncternal-Therapeutics-Provides-Business-Update-and-Announces-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/29/2838399/0/en/Oncternal-Therapeutics-to-Provide-Business-Update-and-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/06/2824764/0/en/Oncternal-Therapeutics-to-Participate-in-Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference.html
https://www.globenewswire.com//news-release/2024/02/01/2822037/0/en/Oncternal-Therapeutics-Reports-Inducement-Award-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2024/01/08/2805505/0/en/Oncternal-Therapeutics-Enrolls-Patients-into-the-Third-Dosing-Cohort-of-its-Phase-1-2-Study-of-ONCT-534-for-the-Treatment-of-R-R-Metastatic-Castration-Resistant-Prostate-Cancer.html
https://www.globenewswire.com//news-release/2024/01/04/2804028/0/en/Oncternal-Therapeutics-Announces-Reverse-Stock-Split.html